Share information
242.70 €
-1.46 %
24/04/2026 12:55
-1.46 %
Open
High
Low
Volume
244.10 €
244.40 €
240.40 €
24,870
Latest News
17-Apr-2026
UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science
17-Apr-2026
Acquisition of own shares
15-Apr-2026
UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at AAN 2026 meeting
10-Apr-2026
Acquisition of own shares